{"id":1015779,"date":"2026-10-30T09:05:27","date_gmt":"2026-10-30T13:05:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/"},"modified":"2026-10-30T09:05:27","modified_gmt":"2026-10-30T13:05:27","slug":"bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/","title":{"rendered":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources"},"content":{"rendered":"<h2>\nRedesigned site brings together information on BGLC\u2019s operating businesses, healthcare initiatives and public disclosures<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>KUALA LUMPUR, Malaysia, Oct.  30, 2026  (GLOBE NEWSWIRE) &#8212; BioNexus Gene Lab Corp. (Nasdaq: BGLC) (\u201cBioNexus\u201d or the \u201cCompany\u201d) today announced the launch of its redesigned corporate website at www.bionexusgenelab.com, providing investors, business partners and other visitors with a more comprehensive view of the Company\u2019s operations and development initiatives.<\/p>\n<p>The website brings together information about MRNA Scientific\u2019s RNA screening business, Chemrex\u2019s industrial chemical and composite-materials business, and BioNexus\u2019 recent healthcare investments and technology relationships. Dedicated technology pages explain blood-based genomic screening and the VitaGuard\u2122 molecular residual disease platform, including their respective applications and development context.<\/p>\n<p>An expanded investor-relations section provides access to annual and quarterly reports, SEC filings, corporate governance materials and shareholder information. The newsroom brings together company announcements, events and presentation resources.<\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <em>\u201cInvestors and potential partners should be able to understand what BioNexus operates today, what we are developing and how our technology relationships fit together. The new website brings that information into one place and gives visitors a clearer route to our public reporting and the people responsible for advancing the business.\u201d<\/em><br \/>\n            <br \/>\n            <strong><br \/>\n              <br \/>Sam Tan, Chief Executive Officer, BioNexus Gene Lab Corp.<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>Visitors can explore the redesigned website at www.bionexusgenelab.com.<\/p>\n<p>The Company\u2019s website address is provided solely for informational purposes. Information contained on, or accessible through, the Company\u2019s website is not part of this press release and is not incorporated by reference into this press release.<\/p>\n<p>\n        <strong>About BioNexus Gene Lab Corp.<\/strong>\n      <\/p>\n<p>BioNexus Gene Lab Corp. (Nasdaq: BGLC) is a technology-focused company operating across biotechnology, precision diagnostics and specialty materials. Through its subsidiaries, investments and licensing arrangements, the Company is developing new healthcare and life-science businesses alongside its established operations.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.<\/p>\n<p>These statements include expectations concerning the website\u2019s contribution to investor communications and engagement with business partners, and the Company\u2019s healthcare and life-science development initiatives. Actual results may differ materially because of implementation and maintenance requirements, cybersecurity and service availability, development and regulatory requirements, funding and execution risks, and other risks described in the Company\u2019s latest Form 10-K, subsequent Forms 10-Q and other SEC filings. Forward-looking statements speak only as of the date made. BioNexus undertakes no obligation to update them except as required by law.<\/p>\n<p>\n        <strong>Investor Relations and Corporate Communications<\/strong>\n      <\/p>\n<p>BioNexus Gene Lab Corp.<br \/>ir@bionexusgenelab.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGZhMWQ0NzctN2MyNy00ZTc2LTkxNmItYmVjZDJjODQ0YzVkLTEzMDI1NzktMjAyNi0xMC0zMC1lbg==\/tiny\/BioNexus-Gene-Lab-Corp-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Redesigned site brings together information on BGLC\u2019s operating businesses, healthcare initiatives and public disclosures KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) &#8212; BioNexus Gene Lab Corp. (Nasdaq: BGLC) (\u201cBioNexus\u201d or the \u201cCompany\u201d) today announced the launch of its redesigned corporate website at www.bionexusgenelab.com, providing investors, business partners and other visitors with a more comprehensive view of the Company\u2019s operations and development initiatives. The website brings together information about MRNA Scientific\u2019s RNA screening business, Chemrex\u2019s industrial chemical and composite-materials business, and BioNexus\u2019 recent healthcare investments and technology relationships. Dedicated technology pages explain blood-based genomic screening and the VitaGuard\u2122 molecular residual disease platform, including their respective applications and development context. An expanded investor-relations section provides access to annual and quarterly reports, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioNexus Launches New Corporate Website with Expanded Business and Investor Resources&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1015779","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Redesigned site brings together information on BGLC\u2019s operating businesses, healthcare initiatives and public disclosures KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) &#8212; BioNexus Gene Lab Corp. (Nasdaq: BGLC) (\u201cBioNexus\u201d or the \u201cCompany\u201d) today announced the launch of its redesigned corporate website at www.bionexusgenelab.com, providing investors, business partners and other visitors with a more comprehensive view of the Company\u2019s operations and development initiatives. The website brings together information about MRNA Scientific\u2019s RNA screening business, Chemrex\u2019s industrial chemical and composite-materials business, and BioNexus\u2019 recent healthcare investments and technology relationships. Dedicated technology pages explain blood-based genomic screening and the VitaGuard\u2122 molecular residual disease platform, including their respective applications and development context. An expanded investor-relations section provides access to annual and quarterly reports, &hellip; Continue reading &quot;BioNexus Launches New Corporate Website with Expanded Business and Investor Resources&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-30T13:05:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources\",\"datePublished\":\"2026-10-30T13:05:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/\"},\"wordCount\":423,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/\",\"name\":\"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\",\"datePublished\":\"2026-10-30T13:05:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/","og_locale":"en_US","og_type":"article","og_title":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk","og_description":"Redesigned site brings together information on BGLC\u2019s operating businesses, healthcare initiatives and public disclosures KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) &#8212; BioNexus Gene Lab Corp. (Nasdaq: BGLC) (\u201cBioNexus\u201d or the \u201cCompany\u201d) today announced the launch of its redesigned corporate website at www.bionexusgenelab.com, providing investors, business partners and other visitors with a more comprehensive view of the Company\u2019s operations and development initiatives. The website brings together information about MRNA Scientific\u2019s RNA screening business, Chemrex\u2019s industrial chemical and composite-materials business, and BioNexus\u2019 recent healthcare investments and technology relationships. Dedicated technology pages explain blood-based genomic screening and the VitaGuard\u2122 molecular residual disease platform, including their respective applications and development context. An expanded investor-relations section provides access to annual and quarterly reports, &hellip; Continue reading \"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-30T13:05:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources","datePublished":"2026-10-30T13:05:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/"},"wordCount":423,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/","name":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=","datePublished":"2026-10-30T13:05:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Njg0NCM3OTI2MTc1IzIyOTEwMjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionexus-launches-new-corporate-website-with-expanded-business-and-investor-resources\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioNexus Launches New Corporate Website with Expanded Business and Investor Resources"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1015779"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015779\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1015779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1015779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1015779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}